334 related articles for article (PubMed ID: 34751002)
1. Referral and adjuvant treatment patterns after nephrectomy in high-risk locoregional renal cell carcinoma.
Dzimitrowicz H; Esterberg E; Miles L; Zanotti G; Borham A; Harrison MR
Cancer Med; 2021 Dec; 10(24):8891-8898. PubMed ID: 34751002
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant Sunitinib for High-risk Renal Cell Carcinoma After Nephrectomy: Subgroup Analyses and Updated Overall Survival Results.
Motzer RJ; Ravaud A; Patard JJ; Pandha HS; George DJ; Patel A; Chang YH; Escudier B; Donskov F; Magheli A; Carteni G; Laguerre B; Tomczak P; Breza J; Gerletti P; Lechuga M; Lin X; Casey M; Serfass L; Pantuck AJ; Staehler M
Eur Urol; 2018 Jan; 73(1):62-68. PubMed ID: 28967554
[TBL] [Abstract][Full Text] [Related]
3. Real-world study on the characteristics, post-nephrectomy journey, and outcomes of patients with early-stage renal cell carcinoma based on risk groups.
Karam JA; Bhattacharya R; Ogbomo A; Gautam S; Yu R; Sundaram M; Imai K; Chhabra J; Haas NB
Cancer Med; 2024 Jun; 13(11):e7247. PubMed ID: 38826126
[TBL] [Abstract][Full Text] [Related]
4. Survival outcomes and practice trends for off-label use of adjuvant targeted therapy in high-risk locoregional renal cell carcinoma.
Chakiryan NH; Acevedo AM; Garzotto MA; Chen Y; Liu JJ; Isharwal S; Amling CL; Kopp RP
Urol Oncol; 2020 Jun; 38(6):604.e1-604.e7. PubMed ID: 32241693
[TBL] [Abstract][Full Text] [Related]
5. Sorafenib or sunitinib as postoperative adjuvant therapy for Chinese patients with locally advanced clear cell renal cell carcinoma at high risk for disease recurrence.
Zhao J; Zhu Y; Zhang C; Wang X; He H; Wang H; Wu Y; Zhou W; Shen Z
Urol Oncol; 2013 Nov; 31(8):1800-5. PubMed ID: 22658883
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant and neoadjuvant therapy for renal cell carcinoma: a survey of the Society of Urologic Oncology.
Tobert CM; Uzzo RG; Wood CG; Lane BR
Urol Oncol; 2013 Oct; 31(7):1316-20. PubMed ID: 22264501
[TBL] [Abstract][Full Text] [Related]
7. Post nephrectomy management of localized renal cell carcinoma. From risk stratification to therapeutic evidence in an evolving clinical scenario.
Ciccarese C; Strusi A; Arduini D; Russo P; Palermo G; Foschi N; Racioppi M; Tortora G; Iacovelli R
Cancer Treat Rev; 2023 Apr; 115():102528. PubMed ID: 36905896
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant 5-flurouracil, alpha-interferon and interleukin-2 versus observation in patients at high risk of recurrence after nephrectomy for renal cell carcinoma: results of a phase III randomised European Organisation for Research and Treatment of Cancer (Genito-Urinary Cancers Group)/National Cancer Research Institute trial.
Aitchison M; Bray CA; Van Poppel H; Sylvester R; Graham J; Innes C; McMahon L; Vasey PA
Eur J Cancer; 2014 Jan; 50(1):70-7. PubMed ID: 24074763
[TBL] [Abstract][Full Text] [Related]
9. Efficacy Assessment of Post-nephrectomy Adjuvant Therapies in Patients with Renal Cell Carcinoma.
Ding K; Yang Z; Zhang D; Sun L
Ann Surg Oncol; 2024 Jun; 31(6):3894-3905. PubMed ID: 38494564
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the intact specimen after laparoscopic radical nephrectomy for clinically localized renal cell carcinoma identifies a subset of patients at increased risk for recurrence.
Cohen DD; Matin SF; Steinberg JR; Zagone R; Wood CG
J Urol; 2005 May; 173(5):1487-90; discussion 1490-1. PubMed ID: 15821465
[TBL] [Abstract][Full Text] [Related]
11. Local and Regional Recurrences of Clinically Localized Renal Cell Carcinoma after Nephrectomy: A 15 Year Institutional Experience with Prognostic Features and Oncologic Outcomes.
Ray S; Cheaib JG; Biles MJ; Pineault KG; Johnson MH; Ged YMA; Markowski MC; Singla N; Allaf ME; Pierorazio PM
Urology; 2021 Aug; 154():201-207. PubMed ID: 33864855
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy.
Ravaud A; Motzer RJ; Pandha HS; George DJ; Pantuck AJ; Patel A; Chang YH; Escudier B; Donskov F; Magheli A; Carteni G; Laguerre B; Tomczak P; Breza J; Gerletti P; Lechuga M; Lin X; Martini JF; Ramaswamy K; Casey M; Staehler M; Patard JJ;
N Engl J Med; 2016 Dec; 375(23):2246-2254. PubMed ID: 27718781
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for locoregional relapse after radical nephrectomy.
Jhavar S; Swanson G; Pruszynski J
Asia Pac J Clin Oncol; 2018 Jun; 14(3):192-197. PubMed ID: 28488392
[TBL] [Abstract][Full Text] [Related]
14. A prospective study of pediatric and adolescent renal cell carcinoma: A report from the Children's Oncology Group AREN0321 study.
Geller JI; Cost NG; Chi YY; Tornwall B; Cajaiba M; Perlman EJ; Kim Y; Mullen EA; Glick RD; Khanna G; Daw NC; Ehrlich P; Fernandez CV; Dome JS;
Cancer; 2020 Dec; 126(23):5156-5164. PubMed ID: 32926409
[TBL] [Abstract][Full Text] [Related]
15. Surgical excision of isolated renal-bed recurrence after radical nephrectomy for renal cell carcinoma.
Sandhu SS; Symes A; A'Hern R; Sohaib SA; Eisen T; Gore M; Christmas TJ
BJU Int; 2005 Mar; 95(4):522-5. PubMed ID: 15705072
[TBL] [Abstract][Full Text] [Related]
16. A Plea for Optimizing Selection in Current Adjuvant Immunotherapy Trials for High-risk Nonmetastatic Renal Cell Carcinoma According to Expected Cancer-specific Mortality.
Palumbo C; Mazzone E; Mistretta FA; Knipper S; Perrotte P; Shariat SF; Saad F; Kapoor A; Lattouf JB; Simeone C; Briganti A; Antonelli A; Karakiewicz PI
Clin Genitourin Cancer; 2020 Aug; 18(4):314-321.e1. PubMed ID: 32482565
[TBL] [Abstract][Full Text] [Related]
17. Risk Factors and Patterns of Locoregional Recurrence after Radical Nephrectomy for Locally Advanced Renal Cell Carcinoma.
Yoo GS; Park W; Pyo H; Jeong BC; Jeon HG; Kang M; Seo SI; Jeon SS; Lee HM; Choi HY; Park BK; Kim CK; Park SY; Kwon GY
Cancer Res Treat; 2022 Jan; 54(1):218-225. PubMed ID: 33857365
[TBL] [Abstract][Full Text] [Related]
18. Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy.
Itano NB; Blute ML; Spotts B; Zincke H
J Urol; 2000 Aug; 164(2):322-5. PubMed ID: 10893575
[TBL] [Abstract][Full Text] [Related]
19. Low Rate of Cancer Events After Partial Nephrectomy for Renal Cell Carcinoma: Clinicopathologic Analysis of 1994 Cases with Emphasis on Definition of "Recurrence".
Bertolo R; Nicolas M; Garisto J; Magi-Galluzzi C; McKenney JK; Kaouk J
Clin Genitourin Cancer; 2019 Jun; 17(3):209-215.e1. PubMed ID: 31000486
[TBL] [Abstract][Full Text] [Related]
20. A network meta-analysis evaluating the efficacy and safety of adjuvant therapy after nephrectomy in renal cell carcinoma.
Guo L; An T; Huang Z; Chong T
BMC Urol; 2024 Mar; 24(1):55. PubMed ID: 38454397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
